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Abstract 
Background: The composition of plaque impacts the results of stenting. The following 
study evaluated plaque redistribution related to stent implantation using combined near-
infrared spectroscopy and intravascular ultrasound (NIRS-IVUS) imaging.  
Methods: The present study included 49 patients (mean age 66 ± 11 years, 75% males) 
presenting with non-ST elevation myocardial infarction (8%), unstable angina (49%) and 
stable coronary artery disease (43%).  The following parameters were analyzed: mean 
plaque volume (MPV, mm3), plaque burden (PB, %), remodeling index (RI), and 
maximal lipid core burden index in a 4 mm segment (maxLCBI4mm). High-lipid burden 
lesions (HLB) were defined as by maxLCBI4mm > 265 with positive RI. Otherwise 
plaques were defined as low-lipid burden lesions (LLB). Measurements were done in the 
target lesion and in 4 mm edges of the stent before and after stent implantation.   
Results: MPV and maxLCBI4mm decreased in both HLB (MPV 144.70 [80.47, 274.25] 
vs. 97.60 [56.82, 223.45]; maxLCBI4mm: 564.11 ± 166.82 vs. 258.11 ± 234.24, p = 0.004) 
and LLB (MPV: 124.50 [68.00, 186.20] vs. 101.10 [67.87, 165.95]; maxLCBI4mm: 
339.07 ± 268.22 vs. 124.60 ± 160.96, p < 0.001), but MPV decrease was greater in HLB 
(28.00 [22.60, 57.10] vs. 13.50 [1.50, 28.84], p = 0.019). Only at the proximal stent edge 
of LLB, maxLCBI4mm decreased (34 [0, 207] vs. 0 [0, 45], p = 0.049) and plaque burden 
increased (45.48 [40.34, 51.55] vs. 51.75 [47.48, 55.76], p = 0.030). 
Conclusions: NIRS-IVUS defined HLB characterized more significant decreases in 
plaque volume by stenting. Plaque redistribution to the proximal edge of the implanted 
stent occurred only in LLB.  
Key words: plaque redistribution, stenting, intravascular ultrasound, near-infrared 
spectroscopy, stent edges 
 
 
Introduction 
Percutaneous coronary intervention (PCI) resolves ischemia by axial displacement 
of atherosclerotic plaque and increase of luminal area. However, the lipidic plaque is 
known to redistribute not only axially, but also longitudinally leading to tissue protrusion 
and stenosis at the stent edges. Both plaque protrusion [1, 2] and reference vessel disease 
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have been identified as predictors of poor outcome after PCI [3]. Intravascular imaging 
modalities like intravascular ultrasound (IVUS), optical coherence tomography (OCT) 
and near-infrared spectroscopy (NIRS) provide insight into the morphology and 
composition of atherosclerotic plaque in vivo. OCT provides superior resolution, but its 
limited penetration depth, mainly through lipidic plaque, impairs the global assessment of 
the lesion, especially after stent implantation [4]. Due to superior penetration, IVUS 
overcomes this limitation of OCT, offering a global assessment of the lesion including 
the plaque structure behind the implanted stent [5]. Its combination with NIRS has 
augmented the capabilities of IVUS [6]. NIRS provides simplified algorithm of detection 
of lipid-rich lesions not only in atherosclerotic plaque but also in tissue located behind the 
implanted stent [6].  
NIRS-IVUS studies demonstrated that lipid-rich plaques might be prone to distal 
embolization after stenting because of redistribution of lipidic plaque and release of its 
debris into circulation [7–9]. Indeed, stenting of lipid-rich lesions increases the risk of 
periprocedural myocardial infarction suggesting that plaque redistribution is related to 
composition and morphology [10, 11]. In the current study, the aim was to assess plaque 
redistribution after stent implantation by combined NIRS-IVUS imaging. It was 
hypothesized that the magnitude and geometry of plaque redistribution at the stent edges 
were related to its morphology and lipid content. 
 
Methods 
Study design  
The present study was a prospective single-center study at the Medical University 
of Silesia in Katowice, Poland in which patients with stable coronary artery disease 
(SCAD) or non-ST elevation-acute coronary syndrome (NSTE-ACS) were undergoing 
stent implantation with NIRS-IVUS. The investigators designed the trial and performed a 
retrospective analysis. Investigators assured data accuracy and collected source 
documents for adjudication. TR and MD performed intravascular imaging analysis, data 
management, and biostatistics. The institutional review board approved the study 
protocol. The study conformed to the Declaration of Helsinki and was approved by the 
Local Ethics Committee. All patients gave written informed consent.   
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Participants  
Patients undergoing clinically indicated PCI for NSTE-ACS or SCAD using 
NIRS-IVUS guidance were screened. Patients with cardiogenic shock, New York Heart 
Association (NYHA) IV class heart failure, significant valvular heart disease, in-stent 
restenosis as the target lesion, reference vessel diameter less than 2.5 mm, excessive 
tortuosity, pregnancy, hemophilia, renal failure (creatinine > 1.5 mg/dL), and contrast 
allergy were excluded from the study. 
 
Procedures 
The current study employed combined NIRS-IVUS assessment of the target 
lesion pre- and post-stent implantation. All imaging was performed during the same 
procedure before predilatation or direct stenting, after stenting and final post-dilatation. 
The target lesion was selected at the operator’s discretion after the diagnostic angiogram 
and FFR if needed. There were no complications related to NIRS-IVUS imaging, which 
was performed using heparin anticoagulation (activated clotting time > 300 s) and 
following intracoronary nitroglycerine (100–200 µm) administration. Combined NIRS 
and gray-scale IVUS image acquisition was performed using the commercially available 
TVC Imaging System™ and TVC Insight Catheter (InfraReDx, MA). The tip of the TVC 
catheter was positioned at least 10 mm distal to the imaging target lesion. Subsequently, 
the automated pullback was started at 0.5 mm/s (240 rotations/min) until the TVC 
catheter entered the guiding catheter.  
 
NIRS images analysis 
NIRS map analysis allows the calculation of a lipid core burden index (LCBI). 
LCBI is estimated by dividing the number of yellow pixels per all pixels (without black 
ones) within the analyzed pullback length and are expressed per mill (‰). The maximal 
LCBI was estimated in 4 mm pullback compartments for every analyzed segment pre- 
and post-stenting (maxLCBI4 mm).  
 
Gray-scale intravascular ultrasound image analysis 
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The region of interest (ROI) was defined as the length of the artery covered by the 
stent pre- and post-procedure. Quantitative grey-scale IVUS measurements were 
performed every millimeter in scanned coronary segments pre and post-stenting. Cross-
sectional images were quantified for lumen diameters and area, external elastic 
membrane (EEM) diameters and area, total plaque area, plaque burden, and lumen and 
EEM eccentricity. Additionally, after stenting, the stent area was estimated. The total 
plaque area was calculated as the difference between EEM area and lumen area (pre-
stenting), or as a difference between EEM area and stent area (post-stenting). Plaque 
burden was calculated as total plaque area divided by EEM area × 100 (%). The IVUS 
reference lumen area was defined as the 4 mm located immediately proximal or distal to 
the ROI. The reference EEM area was calculated as an average of the proximal and distal 
EEM area. The remodeling index (RI) was calculated by dividing the EEM area at the 
minimal lumen area (MLA) by reference EEM area. Lesions with RI ≤ 0.95 were defined 
as negatively remodeled, while those with RI ≥ 1.05 were defined as positively 
remodeled. In every segment, a lumen vessel volume, EEM volume and stented volume 
(after stenting) was calculated based on the Simpson rule [mm3]. These data were used to 
estimate plaque volume (pre-stenting: EEM volume – vessel volume, post-stenting: EEM 
volume – stented volume [mm3]). All IVUS measurements were performed for the ROI 
and 1 mm and 4 mm long segments adjacent to the implanted stent (Fig. 1). 
 
Co-registration of NIRS-IVUS pre and post-stenting. 
During NIRS-IVUS pullback, anatomical landmarks were imprinted on the 
chemogram and bookmarked on the IVUS images — i.e., fiducial points, side branches, 
stent edges. Those landmarks allowed matching of NIRS-IVUS images to corresponding 
sections pre- and post-stenting on angiography. 
 
Lipid-rich lesions 
NIRS-IVUS defined high lipid burden lesions (HLB) as lesions with maxLCBI4 
mm > 265 with positive RI [12]. Non-HLB segments were considered as lowlipid burden 
lesions (LLB). NIRS-IVUS data were analyzed off-line using CAAS intravascular 
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software (Pie Medical Imaging BV). Coronary segments with incomplete and/or poor 
quality NIRS, IVUS scans were excluded from analysis (1 coronary segment, 1 patient).  
 
Statistical analysis 
Normality of the distribution of values was assessed using the Kolmogorov-
Smirnov statistic, and homogeneity of variances assessed using the Levene test. For 
normally distributed values, data are presented as mean with standard deviation (SD), for 
non-normally distributed values data are presented as median with interquartile range 
(IQR, 25 percentile, 75 percentile). Normally distributed data were compared using a 
paired t-test, and non-normally distributed data were compared using the Mann-Whitney-
test. The categorical data were compared using the Fisher exact test or χ2 test. A two-
tailed p-value of 0.05 was considered as statistically significant. Data analysis was 
performed using Medcalc software version 17.1.  
 
Results 
Study group 
Between September 2015 and August 2016 intravascular imaging was performed 
in 50 stents implanted in 49 patients with either SCAD (n = 33, 67%) or NSTE-ACS 
syndromes (n = 16, 33%). HLB lesions were identified in 9 patients, and LLB lesions 
were detected in 40 patients (50 ROIs). HLB patients were characterized by a higher 
level of total cholesterol and triglycerides, and trend towards a higher prevalence of 
diabetes. Baseline clinical characteristics are presented in Table 1. 
 
Angiographic data analysis and procedure details 
There were now differences in the location of HLB lesions and LLB lesions — 
left anterior descending artery: 5 (56%) vs. 19 (46%), circumflex artery: 3 (33%) vs. 10 
(24%), ramus intermedius: 0 vs. 1 (2%), left main: 0 vs. 1 (2%), right coronary artery: 1 
(11%) vs. 10 (24%), p = 0.846. Two HLB lesions (22%) and 14 (34%) LLB lesions were 
located in proximal segments of the coronary artery (p = 0.379).  
There were also no differences in type of DES implanted in HLB and LLB lesions 
— everolimus eluting: 7 (78%) vs. 21 (51%), sirolimus eluting 2 (22%) vs. 11 (27%), 
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biolimus eluting 0 vs. 9 (22%); p = 0.106. There were no differences in the stent diameter 
[mm] — 3 (3, 3.5) vs. 3 (3, 3.5), p = 0.250 and stent length [mm] — 15 (12, 24) vs. 22 
(18, 28), p = 0.306 implanted in HLB and LLB lesions. 
 
Plaque modificationof the stented segment 
Both HLB and LLB lesions were characterized by an increase of minimal lumen 
diameter (MLD), minimal lumen area (MLA), lumen volume and EEM volume and a 
decrease of maxLCBI4 mm, total plaque area, plaque burden and plaque volume after 
stenting. Although the plaque volume decreased in both HLB and LLB lesions, the 
change was significantly higher in HLB lesions (Table 2, Fig. 2).Stenting increased 
remodeling index only in LLB lesions, having no impact on the remodeling index in HLB 
lesions.The observed differences in plaque volume correlated with maxLCBI4 mm  before 
stenting (r = 0.48; p < 0.01) in all 50 lesions (Fig. 2). NIRS-IVUS characteristics of 
stented lesions is presented in Table 2. Representative images of plaque modification are 
presented in Figure 3 and Supplementary Figures 1 and 2.  
 
Assessment of the proximal segment adjacent to the stent after the procedure 
In 4 mm proximal segment adjacent to stent, maxLCBI4 mm decreased after 
stenting in LLB lesions — 34 (0, 207) vs. 0 (0, 45), p = 0.049. However, plaque burden 
[%] — 45.48 (40.34, 51.55) vs. 51.75 (47.48, 55.76), p = 0.030 and total plaque area 
[mm2] — 6.30 (5.17, 7.85) vs. 7.05 (6.08, 8.43), p = 0.005 increased in the first 
millimeter adjacent to the implanted stent in LLB lesions. Such plaque modification was 
not observed in HLB lesions. NIRS-IVUS characteristics of proximally segment adjacent 
to the implanted stent is presented in Supplementary Table 1. 
 
Assessment of the distal segment adjacent to the stent after the procedure 
After the procedure, there were no differences in maxLCBI4 mm, plaque burden, 
plaque volume in distal 4 mm segment adjacent to the implanted stent in both HLB and 
LLB lesions. NIRS-IVUS characteristics of the segment located distally to the implanted 
stent is presented in Supplementary Table 2. 
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Discussion 
This study expands previous observations from intravascular imaging on plaque 
redistribution and lipid burden following stenting, using NIRS-IVUS [13]. It is confirmed 
herein, that plaque redistribution caused by stenting is related to its composition. Lipid-
rich lesions characterized a more significant decrease in plaque volume after stenting, 
especially in HLB. Interestingly, plaque redistribution to the proximal edges of the stent 
occurred only in LLB.  
Initial IVUS studies conducted in patients with SCAD demonstrated that stent 
implantation redistributed plaque longitudinally across the vessel to the proximal and 
distal edges of the stent with the potential for release of plaque debris into coronary 
circulation [7–9]. NIRS imaging alone confirmed a lipidic component of these findings 
[15]. Combined NIRS-IVUS imaging has demonstrated that a decrease in LCBI with a 
reduction in plaque volume led to edge redistribution of lipidic plaque in STEMI patients 
[13]. The current study of non-STEMI patients and SCAD patients confirms that stenting 
of HLB lesions is associated with a decrease in plaque volume.   
Interestingly, plaque shift to the proximal stent edge was found only in LLB 
lesions. The smaller lumen volume after stenting LLB suggest that these plaques have a 
smaller potential to be compressed and are less likely to protrude through stent struts. 
Thus it may affect final stent expansion and prone redistribution of LLB plaques to the 
edges of implanted stent edges to make space for the stent. Moreover, as it was shown a 
correlation between HLB lesions and thin fibrous cap atheroma (TFCA) [12, 14], it is 
also possible that LLB lesions are less prone to embolization into the microcirculation 
from a thick cap. Indeed, OCT studies have shown that TFCA correlates with type IVa 
myocardial infarction after PCI [15], and OCT defined TFCA is a strong predictor of 
periprocedural infarction [10]. Taken together the present results suggest that both lipid-
rich plaque and distinct plaque morphology may be necessary to trigger distal 
embolization [16]. Previous studies have shown that the use of aggressive lipid-lowering 
therapy can decrease lipid core and increase fibrous cap thickness [17, 18]. The routine 
use of high-dose statins before planned stent implantation to reduce no-reflow 
phenomenon requires further attention [19]. 
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The Color Registry showed previously that lesions with maxLCBI4 mm > 500 had 
an increased risk of periprocedural myocardial infarction [11]. The findings prompted the 
CANARY trial, which tested the potential benefit of distal protection during PCI for 
lesions with maxLCBI4 mm > 600. The trial failed to show a benefit, perhaps due to the 
inherent morbidity of filter placement but was also stopped prematurely due to 
difficulties in identifying patients suitable for randomization [20]. The present data 
suggests that plaque morphology assessment should also be applied to assess the risk of 
distal embolization.   
The current study showed that LLB lesions had a smaller decrease in plaque 
volume with an increase in plaque area and plaque burden at the proximal edge of the 
implanted stent, but not at the distal edge. It is possible that this is a result of the 
difference in size of the vessel proximally versus distally. The relatively large proximal 
vessel size may be able to accommodate plaque shift to a greater extent than the distal 
edge. Since NIRS cannot determine depth (axial dimension of the lipid), a decreased lipid 
length could result in decreased LCBI values but not an actual reduction in lipid burden, 
rather indicating an axial accumulation [21]. Nevertheless, the plaque shift to the 
proximal edge of the stent advocates use of the “red to red” (healthy to healthy segment) 
stenting strategy to reduce adverse clinical outcomes [22].  
 
Limitations of the study 
The study has several limitations. A small group of patients were included in the 
study, and both acute and stable coronary patients were assessed. The HLB lesion 
definition relied on previously presented NIRS-IVUS data against OCT [12]. The 
addition of OCT imaging to NIRS-IVUS imaging could have improved the accuracy of 
HLB detection in this study. Although there was no strict protocol for stent implantation, 
it does represent real-world practice.  
 
Conclusions 
NIRS-IVUSHLB lesions had a more significant decrease in plaque volume by 
stenting without plaque distribution to the edges of the stent. Plaque redistribution to the 
proximal edge of the implanted stent was observed only in LLB lesions. 
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Table. 1. Patient characteristics. 
 Patients with low lipid 
burden lesions (n = 40) 
Patients with high lipid 
burden lesions (n = 9) 
P 
Age [years] 66.17 ± 11.32 65.5 ± 10.72 0.920 
Male gender  32 (80%)  5 (55%) 0.113 
Body mass index [kg/m2] 26.7 (IQR 25.23, 27.93) 25.15 (IQR 20.70, 36.09) 0.771 
NSTEMI/UA/SCAD 4 (10%)/20 (50%)/16 (30%) 0/5 (55%)/4 (45%) 0.433 
    
Risk factors    
Hypertension 36 (90%) 8 (88%) 0.634 
Hyperlipidemia 40 (100%) 9 (100%) - 
Diabetes mellitus 11 (27%) 6 (67%) 0.058 
Current smoking  3 (7%) 1 (11%) 0.714 
    
Pharmacological therapy    
Acetylsalicylic acid 38 (95%) 8 (88%) 0.765 
Thienopyridine 27 (67%) 3 (33%) 0.153 
Beta-adrenergic antagonist  32 (80%) 6 (67%) 0.519 
Calcium channel antagonist  10 (25%) 5 (56%) 0.148 
ARB/ACEI 27 (67%) 6 (67%) 0.732 
Statin 36 (90%) 9 (100%) 0.623 
Other lipid-lowering therapy 4 (10%) 2 (22%) 0.654 
Oral antidiabetics 10 (25%) 5 (56%) 0.148 
Insulin 1 (2%) 1 (11%) 0.792 
    
Laboratory results    
Total cholesterol [mg/dL] 139 (IQR 127, 153) 171 (IQR 146.92, 244.64) 0.031 
LDL cholesterol [mg/dL] 76 (IQR 69, 93) 99.00 (IQR 69.69, 132.03) 0.120 
HDL cholesterol [mg/dL] 40.00 (IQR 36.76, 46.00) 44.50 (IQR 38.67, 50.16) 0.401 
Triglyceride [mg/dL] 102.02 (IQR 91.58, 115.19) 154.50 (IQR 98.10, 
355.03) 
0.012 
GRF [mL/min/1.73 m2] 72.40 ± 15.93 67.62 ± 25.84 0.473 
 
NSTEMI — non ST elevation myocardial infarction, UA — unstable angina, SCAD — stable coronary 
artery disease, ARB — angiotensin II receptor blocker, ACE — angiotensin-converting-enzyme inhibitor; 
LDL — low dense lipids, HDL — high-dens lipids, GRF — glomerular filtration rate; IQR — interquartile 
range 
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Table 2. Near-infrared spectroscopy and intravascular ultrasound results of the stented segment. 
ROI — region of interest; MLD — minimal lumen diameter; MLA — minimal lumen area; EEM — external elastic lamina; maxLCBI4 mm — maximal lipid core burden index in 
four millimeters; ΔMPV — delta plaque volume 
 
 Low lipid burden lesions (n = 41)  High lipid burden lesions (n = 9)  
Parameters  Pre-stenting Post-stenting P Pre-stenting Post-stenting P 
Stented segment:       
ROI [mm] 21.98 ± 9.01 21.96 ± 8.98 0.804 25.71 ± 15.38 25.70 ± 15.39 0.346 
MLD [mm] 1.64 ± 0.31 2.23 ± 0.37 < 0.001 1.53 ± 0.13 2.28 ± 0.34 < 0.001 
MLA [mm2] 2.65 ± 1.21 5.31 ± 1.68 < 0.001 2.94 ± 1.40 6.15 ± 1.39 < 0.001 
Stenosis (MLA) on 
reference [%] 
55.36 ± 13.01 17.90 ± 14.38 < 0.001 
57.63 ± 10.19 19.00 ± 14.78 0.006 
Lumen volume [mm3] 98.80 (63.15, 131.45) 128.30 (86.97, 185.37) < 0.001 96.70 (69.10, 112.62) 181.30 (76.22, 266.37) 0.004 
EEM volume [mm3] 226.70 (140.77, 315.82) 288.60 (169.42, 377.62) < 0.001 244.40 (149.55, 379.10) 317.30 (144.47, 535.52) 0.012 
ΔEEM volume[mm3] 46.45 (21.50, 74.85)   67.40 (16.22, 116.62) 0.423 
Plaque volume [mm3] 124.50 (68.00, 186.20) 101.10 (67.87, 165.95) < 0.001 144.70 (80.47, 274. 25) 97.60 (56.82, 223.45) 0.004 
ΔMPV[mm3] 13.50 (1.50, 28.84)  28.00 (22.60, 57.10) 0.019 
maxLCBI4 mm 339.07 ± 268.22 124.60 ± 160.96 < 0.001 564.11 ± 166.82 258.11 ± 234.24 0.004 
EEM area [mm2] 10.00 (7.50, 11.60) 11.30 (9.27, 13.25) < 0.001 12.70 (12.10, 13.47) 13.10 (11.72, 16.20) 0.820 
EEM eccentricity 0.09 (0.07, 0.15) 0.09 (0.06, 0.13) 0.551 0.09 ± 0.01 0.11 ± 0.04 0.341 
Lumen eccentricity 0.09 (0.06, 0.14) 0.13 (0.08, 0.18) 0.038 0.17 ± 1.12 0.20 ± 0.10 0.181 
Total plaque area [mm2] 7.4 (5.12, 8.62) 4.7 (3.67, 6.40) < 0.001 11.51 ± 5.01 5.72 ± 1.80 0.009 
Plaque burden [%] 72.19 ± 8.12 55.03 ± 6.87 < 0.001 79.26 ± 8.57 53.0 ± 9.9 < 0.001 
Remodeling index 0.87 ± 0.23 1.09 ± 0.27 < 0.001 1.23 ± 0.11 1.20 ± 0.25 0.739 
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Figure 1. Intravascular ultrasound imaging measurements. The figure presents the 
analyzed segment by intravascular ultrasound imaging. The minimal lumen area and 
diameter external elastic lamina area and volume, lumen volume, plaque area volume, 
plaque burden and plaque eccentricity were measured for the region of interest, and for 
proximal and distal 1 mm and 4 mm long segments adjacent to the stent. All 
measurements were performed before and after stenting. 
 
Figure 2. Plaque volume pre- and post-stenting and lipid core burden index (LCBI) 
values. A. The difference in plaque volume for near-infrared spectroscopy and 
intravascular ultrasound (NIRS-IVUS) high lipid burden lesions (HLB, maxLCBI4 mm > 
265 and positive vessel remodeling) and for NIRS-IVUS low lipid burden (LLB) lesions; 
B. The correlation between the difference in plaque volume pre- and post-stenting and 
maxLCBI4mm values in all lesions. 
 
Figure 3. Representative image of near-infrared spectroscopy and intravascular 
ultrasound (NIRS-IVUS) imaging pre- and post-stenting of high lipid burden and low 
lipid burden lesions; A, C. NIRS maps pre- and post-stent implantation. Black lines 
indicate stent edges. Black dashed lines limit 4 mm proximal and distal segments 
adjacent to the stent. White dashed lines indicate the NIRS-IVUS cross-section image. B, 
D. NIRS-IVUS cross-sectional image of minimal lumen area (MLA, green line), external 
elastic lamina (EEM, yellow line) and stent contours (pink line). High lipid burden 
lesion: A. Pre-stenting maxLCBI4 mm = 548; C. Post-stenting maxLCBI4 mm = 202; B. Pre-
stenting: MLA = 3.8 mm2, plaque burden = 71%, plaque area = 9.2 mm2, EEM area = 
12.9 mm2, remodeling index = 1.34; D. Post-stenting: MLA = 6.4mm2, plaque burden = 
48.8%, plaque area = 6.1 mm2, EEM area = 12.4 mm2, stent area = 5.0 mm2, remodeling 
index = 1.22; delta mean plaque volume = 22.9 mm3. Low lipid burden lesion: A. Pre-
stenting maxLCBI4 mm = 137; C. Post-stenting maxLCBI4 mm = 30; B. Pre-stenting: MLA 
= 3.5 mm2, plaque burden = 61%, plaque area = 6.4 mm2, EEM area = 10.6 mm2, 
remodeling index = 0.72; D. Post-stenting: MLA = 5.8 mm2, plaque burden = 53%, 
plaque area = 6.4 mm2, EEM area = 12.0 mm2, stent area = 6.6 mm2, remodeling index = 
1.29; delta mean plaque volume = 8.2 mm3. 



